Report Detail
Global Head and Neck Cancer Drugs/Therapeutics Market Insights, Forecast to 2025
- RnM3421713 |
- 15 May, 2019 |
- Global |
- 113 Pages |
- QYResearch |
- Pharma & Healthcare
Head and neck cancer is a group of cancers that starts in the mouth, nose, throat, larynx, sinuses, or salivary glands.
Current trends indicate that rising geriatric population worldwide, growing cases of target diseases, and availability of improved healthcare services due to government and private organization initiatives will drive the overall market
The global Head and Neck Cancer Drugs/Therapeutics market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Head and Neck Cancer Drugs/Therapeutics market based on company, product type, end user and key regions.
This report studies the global market size of Head and Neck Cancer Drugs/Therapeutics in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Head and Neck Cancer Drugs/Therapeutics in these regions.
This research report categorizes the global Head and Neck Cancer Drugs/Therapeutics market by top players/brands, region, type and end user. This report also studies the global Head and Neck Cancer Drugs/Therapeutics market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Sanofi
Eli Lilly
Amgen
Actavis
Dr. Reddy’s Laboratories
Jiangsu Hengrui
Teva Pharmaceutical
DFG
BioXpress
Market size by Product
PD Inhibitors
Microtubule Inhibitors
EGFR Inhibitors
Market size by End User
Surgery
Radiation therapy
Chemotherapy
Immunotherapy
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Head and Neck Cancer Drugs/Therapeutics market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Head and Neck Cancer Drugs/Therapeutics market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Head and Neck Cancer Drugs/Therapeutics companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Head and Neck Cancer Drugs/Therapeutics submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Head and Neck Cancer Drugs/Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Head and Neck Cancer Drugs/Therapeutics market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Head and Neck Cancer Drugs/Therapeutics Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Head and Neck Cancer Drugs/Therapeutics Market Size Growth Rate by Product
- 1.4.2 PD Inhibitors
- 1.4.3 Microtubule Inhibitors
- 1.4.4 EGFR Inhibitors
- 1.5 Market by End User
- 1.5.1 Global Head and Neck Cancer Drugs/Therapeutics Market Size Growth Rate by End User
- 1.5.2 Surgery
- 1.5.3 Radiation therapy
- 1.5.4 Chemotherapy
- 1.5.5 Immunotherapy
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Head and Neck Cancer Drugs/Therapeutics Market Size
- 2.1.1 Global Head and Neck Cancer Drugs/Therapeutics Revenue 2014-2025
- 2.1.2 Global Head and Neck Cancer Drugs/Therapeutics Sales 2014-2025
- 2.2 Head and Neck Cancer Drugs/Therapeutics Growth Rate by Regions
- 2.2.1 Global Head and Neck Cancer Drugs/Therapeutics Sales by Regions
- 2.2.2 Global Head and Neck Cancer Drugs/Therapeutics Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Head and Neck Cancer Drugs/Therapeutics Sales by Manufacturers
- 3.1.1 Head and Neck Cancer Drugs/Therapeutics Sales by Manufacturers
- 3.1.2 Head and Neck Cancer Drugs/Therapeutics Sales Market Share by Manufacturers
- 3.1.3 Global Head and Neck Cancer Drugs/Therapeutics Market Concentration Ratio (CR5 and HHI)
- 3.2 Head and Neck Cancer Drugs/Therapeutics Revenue by Manufacturers
- 3.2.1 Head and Neck Cancer Drugs/Therapeutics Revenue by Manufacturers (2014-2019)
- 3.2.2 Head and Neck Cancer Drugs/Therapeutics Revenue Share by Manufacturers (2014-2019)
- 3.3 Head and Neck Cancer Drugs/Therapeutics Price by Manufacturers
- 3.4 Head and Neck Cancer Drugs/Therapeutics Manufacturing Base Distribution, Product Types
- 3.4.1 Head and Neck Cancer Drugs/Therapeutics Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Head and Neck Cancer Drugs/Therapeutics Product Type
- 3.4.3 Date of International Manufacturers Enter into Head and Neck Cancer Drugs/Therapeutics Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Head and Neck Cancer Drugs/Therapeutics Sales by Product
- 4.2 Global Head and Neck Cancer Drugs/Therapeutics Revenue by Product
- 4.3 Head and Neck Cancer Drugs/Therapeutics Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Head and Neck Cancer Drugs/Therapeutics Breakdown Data by End User
6 North America
- 6.1 North America Head and Neck Cancer Drugs/Therapeutics by Countries
- 6.1.1 North America Head and Neck Cancer Drugs/Therapeutics Sales by Countries
- 6.1.2 North America Head and Neck Cancer Drugs/Therapeutics Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Head and Neck Cancer Drugs/Therapeutics by Product
- 6.3 North America Head and Neck Cancer Drugs/Therapeutics by End User
7 Europe
- 7.1 Europe Head and Neck Cancer Drugs/Therapeutics by Countries
- 7.1.1 Europe Head and Neck Cancer Drugs/Therapeutics Sales by Countries
- 7.1.2 Europe Head and Neck Cancer Drugs/Therapeutics Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Head and Neck Cancer Drugs/Therapeutics by Product
- 7.3 Europe Head and Neck Cancer Drugs/Therapeutics by End User
8 Asia Pacific
- 8.1 Asia Pacific Head and Neck Cancer Drugs/Therapeutics by Countries
- 8.1.1 Asia Pacific Head and Neck Cancer Drugs/Therapeutics Sales by Countries
- 8.1.2 Asia Pacific Head and Neck Cancer Drugs/Therapeutics Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Head and Neck Cancer Drugs/Therapeutics by Product
- 8.3 Asia Pacific Head and Neck Cancer Drugs/Therapeutics by End User
9 Central & South America
- 9.1 Central & South America Head and Neck Cancer Drugs/Therapeutics by Countries
- 9.1.1 Central & South America Head and Neck Cancer Drugs/Therapeutics Sales by Countries
- 9.1.2 Central & South America Head and Neck Cancer Drugs/Therapeutics Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Head and Neck Cancer Drugs/Therapeutics by Product
- 9.3 Central & South America Head and Neck Cancer Drugs/Therapeutics by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Head and Neck Cancer Drugs/Therapeutics by Countries
- 10.1.1 Middle East and Africa Head and Neck Cancer Drugs/Therapeutics Sales by Countries
- 10.1.2 Middle East and Africa Head and Neck Cancer Drugs/Therapeutics Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Head and Neck Cancer Drugs/Therapeutics by Product
- 10.3 Middle East and Africa Head and Neck Cancer Drugs/Therapeutics by End User
11 Company Profiles
- 11.1 Sanofi
- 11.1.1 Sanofi Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Sanofi Head and Neck Cancer Drugs/Therapeutics Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Sanofi Head and Neck Cancer Drugs/Therapeutics Products Offered
- 11.1.5 Sanofi Recent Development
- 11.2 Eli Lilly
- 11.2.1 Eli Lilly Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Eli Lilly Head and Neck Cancer Drugs/Therapeutics Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Eli Lilly Head and Neck Cancer Drugs/Therapeutics Products Offered
- 11.2.5 Eli Lilly Recent Development
- 11.3 Amgen
- 11.3.1 Amgen Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Amgen Head and Neck Cancer Drugs/Therapeutics Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Amgen Head and Neck Cancer Drugs/Therapeutics Products Offered
- 11.3.5 Amgen Recent Development
- 11.4 Actavis
- 11.4.1 Actavis Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Actavis Head and Neck Cancer Drugs/Therapeutics Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Actavis Head and Neck Cancer Drugs/Therapeutics Products Offered
- 11.4.5 Actavis Recent Development
- 11.5 Dr. Reddy’s Laboratories
- 11.5.1 Dr. Reddy’s Laboratories Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Dr. Reddy’s Laboratories Head and Neck Cancer Drugs/Therapeutics Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Dr. Reddy’s Laboratories Head and Neck Cancer Drugs/Therapeutics Products Offered
- 11.5.5 Dr. Reddy’s Laboratories Recent Development
- 11.6 Jiangsu Hengrui
- 11.6.1 Jiangsu Hengrui Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Jiangsu Hengrui Head and Neck Cancer Drugs/Therapeutics Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Jiangsu Hengrui Head and Neck Cancer Drugs/Therapeutics Products Offered
- 11.6.5 Jiangsu Hengrui Recent Development
- 11.7 Teva Pharmaceutical
- 11.7.1 Teva Pharmaceutical Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Teva Pharmaceutical Head and Neck Cancer Drugs/Therapeutics Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Teva Pharmaceutical Head and Neck Cancer Drugs/Therapeutics Products Offered
- 11.7.5 Teva Pharmaceutical Recent Development
- 11.8 DFG
- 11.8.1 DFG Company Details
- 11.8.2 Company Business Overview
- 11.8.3 DFG Head and Neck Cancer Drugs/Therapeutics Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 DFG Head and Neck Cancer Drugs/Therapeutics Products Offered
- 11.8.5 DFG Recent Development
- 11.9 BioXpress
- 11.9.1 BioXpress Company Details
- 11.9.2 Company Business Overview
- 11.9.3 BioXpress Head and Neck Cancer Drugs/Therapeutics Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 BioXpress Head and Neck Cancer Drugs/Therapeutics Products Offered
- 11.9.5 BioXpress Recent Development
12 Future Forecast
- 12.1 Head and Neck Cancer Drugs/Therapeutics Market Forecast by Regions
- 12.1.1 Global Head and Neck Cancer Drugs/Therapeutics Sales Forecast by Regions 2019-2025
- 12.1.2 Global Head and Neck Cancer Drugs/Therapeutics Revenue Forecast by Regions 2019-2025
- 12.2 Head and Neck Cancer Drugs/Therapeutics Market Forecast by Product
- 12.2.1 Global Head and Neck Cancer Drugs/Therapeutics Sales Forecast by Product 2019-2025
- 12.2.2 Global Head and Neck Cancer Drugs/Therapeutics Revenue Forecast by Product 2019-2025
- 12.3 Head and Neck Cancer Drugs/Therapeutics Market Forecast by End User
- 12.4 North America Head and Neck Cancer Drugs/Therapeutics Forecast
- 12.5 Europe Head and Neck Cancer Drugs/Therapeutics Forecast
- 12.6 Asia Pacific Head and Neck Cancer Drugs/Therapeutics Forecast
- 12.7 Central & South America Head and Neck Cancer Drugs/Therapeutics Forecast
- 12.8 Middle East and Africa Head and Neck Cancer Drugs/Therapeutics Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Head and Neck Cancer Drugs/Therapeutics Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Head and Neck Cancer Drugs/Therapeutics . Industry analysis & Market Report on Head and Neck Cancer Drugs/Therapeutics is a syndicated market report, published as Global Head and Neck Cancer Drugs/Therapeutics Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Head and Neck Cancer Drugs/Therapeutics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
